Occam’s razor... I think all parties — Cyto
Post# of 148170
I think all parties — Cytodyn and regulatory agencies — are very sensitive to market moving information right now. While discussions continue I don’t think they want any info out there, including the name Leronlimab. They won’t mention it by name anywhere until EUA is applied for OR granted IMO.